Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Sales (2016 - 2025)

Historic Return on Sales for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to 0.15%.

  • Standard Biotools' Return on Sales rose 700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.8% for FY2024, which is 900.0% down from last year.
  • According to the latest figures from Q3 2025, Standard Biotools' Return on Sales is 0.15%, which was up 700.0% from 0.73% recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Return on Sales ranged from a high of 0.15% in Q3 2025 and a low of 3.38% during Q2 2022
  • Moreover, its 5-year median value for Return on Sales was 0.69% (2024), whereas its average is 0.89%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 45800bps in 2021, then crashed by -28300bps in 2022.
  • Over the past 5 years, Standard Biotools' Return on Sales (Quarter) stood at 0.25% in 2021, then plummeted by -213bps to 0.77% in 2022, then increased by 9bps to 0.71% in 2023, then grew by 2bps to 0.69% in 2024, then soared by 78bps to 0.15% in 2025.
  • Its Return on Sales was 0.15% in Q3 2025, compared to 0.73% in Q2 2025 and 0.64% in Q1 2025.